Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study.

Calabrese, Joseph R; Jin, Na; Johnson, Brian; Such, Pedro; Baker, Ross A; Madera, Jessica; Hertel, Peter; Ottinger, Jocelyn; Amatniek, Joan; Kawasaki, Hiroaki

Calabrese, Joseph R; Jin, Na; Johnson, Brian; Such, Pedro; Baker, Ross A; Madera, Jessica; Hertel, Peter; Ottinger, Jocelyn; Amatniek, Joan; Kawasaki, Hiroaki.

Afiliação

Calabrese JR; University Hospitals Cleveland Medical Center, 10524 Euclid Avenue, Cleveland, OH, 44106, USA. joseph.calabrese@uhhospitals.org.
Jin N; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Johnson B; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Such P; H. Lundbeck A/S, Valby, Denmark.
Baker RA; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Madera J; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Hertel P; H. Lundbeck A/S, Valby, Denmark.
Ottinger J; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Amatniek J; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Kawasaki H; Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Int J Bipolar Disord ; 6(1): 14, 2018 Jun 10.

Article em En | MEDLINE | ID: mdl-29886522

Palavras-chave

Aripiprazole once-monthly; Bipolar I disorder; Maintenance treatment; Patient satisfaction; Safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Int J Bipolar Disord Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google